<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36069885</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6238</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA psychiatry</Title><ISOAbbreviation>JAMA Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post-COVID-19 Conditions.</ArticleTitle><Pagination><StartPage>1081</StartPage><EndPage>1091</EndPage><MedlinePgn>1081-1091</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamapsychiatry.2022.2640</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Few risk factors for long-lasting (&#x2265;4 weeks) COVID-19 symptoms have been identified.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether high levels of psychological distress before SARS-CoV-2 infection, characterized by depression, anxiety, worry, perceived stress, and loneliness, are prospectively associated with increased risk of developing post-COVID-19 conditions (sometimes called long COVID).</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This prospective cohort study used data from 3 large ongoing, predominantly female cohorts: Nurses' Health Study II, Nurses' Health Study 3, and the Growing Up Today Study. Between April 2020 and November 2021, participants were followed up with periodic surveys. Participants were included if they reported no current or prior SARS-CoV-2 infection at the April 2020 baseline survey when distress was assessed and returned 1 or more follow-up questionnaires.</AbstractText><AbstractText Label="EXPOSURES">Depression, anxiety, worry about COVID-19, perceived stress, and loneliness were measured at study baseline early in the pandemic, before SARS-CoV-2 infection, using validated questionnaires.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">SARS-CoV-2 infection was self-reported during each of 6 monthly and then quarterly follow-up questionnaires. COVID-19-related symptoms lasting 4 weeks or longer and daily life impairment due to these symptoms were self-reported on the final questionnaire, 1 year after baseline.</AbstractText><AbstractText Label="RESULTS">Of 54&#x202f;960 participants, 38.0% (n&#x2009;=&#x2009;20&#x202f;902) were active health care workers, and 96.6% (n&#x2009;=&#x2009;53&#x202f;107) were female; the mean (SD) age was 57.5 (13.8) years. Six percent (3193 participants) reported a positive SARS-CoV-2 test result during follow-up (1-47 weeks after baseline). Among these, probable depression (risk ratio [RR], 1.32; 95% CI&#x2009;=&#x2009;1.12-1.55), probable anxiety (RR&#x2009;=&#x2009;1.42; 95% CI, 1.23-1.65), worry about COVID-19 (RR, 1.37; 95% CI, 1.17-1.61), perceived stress (highest vs lowest quartile: RR, 1.46; 95% CI, 1.18-1.81), and loneliness (RR, 1.32; 95% CI, 1.08-1.61) were each associated with post-COVID-19 conditions (1403 cases) in generalized estimating equation models adjusted for sociodemographic factors, health behaviors, and comorbidities. Participants with 2 or more types of distress prior to infection were at nearly 50% increased risk for post-COVID-19 conditions (RR, 1.49; 95% CI, 1.23-1.80). All types of distress were associated with increased risk of daily life impairment (783 cases) among individuals with post-COVID-19 conditions (RR range, 1.15-1.51).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">The findings of this study suggest that preinfection psychological distress may be a risk factor for post-COVID-19 conditions in individuals with SARS-CoV-2 infection. Future work should examine the biobehavioral mechanism linking psychological distress with persistent postinfection symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Siwen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quan</LastName><ForeName>Luwei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chavarro</LastName><ForeName>Jorge E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slopen</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubzansky</LastName><ForeName>Laura D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koenen</LastName><ForeName>Karestan C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Psychiatric Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Jae Hee</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weisskopf</LastName><ForeName>Marc G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Branch-Elliman</LastName><ForeName>Westyn</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>VA Boston Healthcare System, Department of Medicine, Section of Infectious Diseases, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Andrea L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 HL145386</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R24 ES028521</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HD094725</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA176726</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HD057368</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Psychiatry</MedlineTA><NlmUniqueID>101589550</NlmUniqueID><ISSNLinking>2168-622X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>JAMA Psychiatry. 2022 Nov 1;79(11):1141. doi: 10.1001/jamapsychiatry.2022.3336</RefSource><PMID Version="1">36169981</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008132" MajorTopicYN="N">Loneliness</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Chavarro reported grants to his institution from the National Institutes of Health (NIH) during the conduct of the study and grants to his institution from the NIH, US Food and Drug Administration, and Centers for Disease Control and Prevention outside the submitted work. Dr Kubzansky reported grants from the NIH and support for data collection from the Lee Kum Sheung Center for Health and Happiness during the conduct of the study. Dr Koenen reported a Dean&#x2019;s Acceleration Award internal grant from Harvard T.H. Chan School of Public Health during the conduct of the study. Dr Branch-Elliman reported being the site principal investigator for a COVID-19 therapeutics study funded by Gilead Sciences (funds provided to her institution) during the conduct of the study. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>7</Day><Hour>13</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36069885</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pii">2796097</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. doi:10.1016/S2213-2600(21)00031-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-631. doi:10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al. . Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2):e210830. doi:10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. ; PHOSP-COVID Collaborative Group . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275-1287. doi:10.1016/S2213-2600(21)00383-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi:10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerlind E, Palstam A, Sunnerhagen KS, Persson HC. Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort. BMC Public Health. 2021;21(1):1023. doi:10.1186/s12889-021-11013-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11013-2</ArticleId><ArticleId IdType="pmc">PMC8164957</ArticleId><ArticleId IdType="pubmed">34059034</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417. doi:10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. . Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568. doi:10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>FAIR Health . A detailed study of patients with long-haul COVID: an analysis of private healthcare claims. Published June 15, 2021. https://www.fairhealth.org/publications/whitepapers</Citation></Reference><Reference><Citation>Rando HM, Bennett TD, Byrd JB, et al. . Challenges in defining long COVID: striking differences across literature, electronic health records, and patient-reported information. medRxiv. Published online March 26, 2021. doi:10.1101/2021.03.20.21253896</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. ; IVY Network Investigators; CDC COVID-19 Response Team; IVY Network Investigators . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network: United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-998. doi:10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, et al. ; COVID19-ALC research group . Post-acute COVID-19 syndrome, incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378-383. doi:10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. ; ISB-Swedish COVID-19 Biobanking Unit . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881-895.e20. doi:10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Falagas ME, Karamanidou C, Kastoris AC, Karlis G, Rafailidis PI. Psychosocial factors and susceptibility to or outcome of acute respiratory tract infections. Int J Tuberc Lung Dis. 2010;14(2):141-148.</Citation><ArticleIdList><ArticleId IdType="pubmed">20074403</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S, Doyle WJ, Skoner DP. Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom Med. 1999;61(2):175-180. doi:10.1097/00006842-199903000-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006842-199903000-00009</ArticleId><ArticleId IdType="pubmed">10204970</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett JW, Wainberg M, Elkind MSV, Freedberg DE. Potential long coronavirus disease 2019 gastrointestinal symptoms 6 months after coronavirus infection are associated with mental health symptoms. Gastroenterology. 2022;162(2):648-650.e2. doi:10.1053/j.gastro.2021.10.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.040</ArticleId><ArticleId IdType="pmc">PMC8556689</ArticleId><ArticleId IdType="pubmed">34728186</ArticleId></ArticleIdList></Reference><Reference><Citation>Garjani A, Middleton RM, Nicholas R, Evangelou N. Recovery from COVID-19 in multiple sclerosis: a prospective and longitudinal cohort study of the United Kingdom Multiple Sclerosis Register. Neurol Neuroimmunol Neuroinflamm. 2021;9(1):e1118. doi:10.1212/NXI.0000000000001118</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001118</ArticleId><ArticleId IdType="pmc">PMC8631790</ArticleId><ArticleId IdType="pubmed">34848503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer ME, Teixeira AL. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci. 2019;1437(1):57-67. doi:10.1111/nyas.13712</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13712</ArticleId><ArticleId IdType="pubmed">29752710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouayed J, Rammal H, Soulimani R. Oxidative stress and anxiety: relationship and cellular pathways. Oxid Med Cell Longev. 2009;2(2):63-67. doi:10.4161/oxim.2.2.7944</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/oxim.2.2.7944</ArticleId><ArticleId IdType="pmc">PMC2763246</ArticleId><ArticleId IdType="pubmed">20357926</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajpai A, Verma AK, Srivastava M, Srivastava R. Oxidative stress and major depression. J Clin Diagn Res. 2014;8(12):CC04-CC07. doi:10.7860/JCDR/2014/10258.5292</Citation><ArticleIdList><ArticleId IdType="doi">10.7860/JCDR/2014/10258.5292</ArticleId><ArticleId IdType="pmc">PMC4316245</ArticleId><ArticleId IdType="pubmed">25653939</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohleder N. Stimulation of systemic low-grade inflammation by psychosocial stress. Psychosom Med. 2014;76(3):181-189. doi:10.1097/PSY.0000000000000049</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000049</ArticleId><ArticleId IdType="pubmed">24608036</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19(1):11-38. doi:10.1016/0278-5846(94)00101-M</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0278-5846(94)00101-M</ArticleId><ArticleId IdType="pubmed">7708925</ArticleId></ArticleIdList></Reference><Reference><Citation>Killgore WDS, Cloonan SA, Taylor EC, Lucas DA, Dailey NS. Loneliness during the first half-year of COVID-19 lockdowns. Psychiatry Res. 2020;294:113551. doi:10.1016/j.psychres.2020.113551</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113551</ArticleId><ArticleId IdType="pubmed">33171416</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu F, Steptoe A, Fancourt D. Who is lonely in lockdown? cross-cohort analyses of predictors of loneliness before and during the COVID-19 pandemic. Public Health. 2020;186:31-34. doi:10.1016/j.puhe.2020.06.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2020.06.036</ArticleId><ArticleId IdType="pmc">PMC7405905</ArticleId><ArticleId IdType="pubmed">32768621</ArticleId></ArticleIdList></Reference><Reference><Citation>Charles NE, Strong SJ, Burns LC, Bullerjahn MR, Serafine KM. Increased mood disorder symptoms, perceived stress, and alcohol use among college students during the COVID-19 pandemic. Psychiatry Res. 2021;296:113706. doi:10.1016/j.psychres.2021.113706</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2021.113706</ArticleId><ArticleId IdType="pmc">PMC7781902</ArticleId><ArticleId IdType="pubmed">33482422</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen J, Lund R, Qualter P, Andersen CM, Pedersen SS, Lasgaard M. Loneliness, social isolation, and chronic disease outcomes. Ann Behav Med. 2021;55(3):203-215. doi:10.1093/abm/kaaa044</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abm/kaaa044</ArticleId><ArticleId IdType="pubmed">32865550</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopp MS, R&#xe9;thelyi J. Where psychology meets physiology, chronic stress and premature mortality: the Central-Eastern European health paradox. Brain Res Bull. 2004;62(5):351-367. doi:10.1016/j.brainresbull.2003.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2003.12.001</ArticleId><ArticleId IdType="pubmed">15168900</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao Y, Bertoia ML, Lenart EB, et al. . Origin, methods, and evolution of the three Nurses&#x2019; Health Studies. Am J Public Health. 2016;106(9):1573-1581. doi:10.2105/AJPH.2016.303338</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2016.303338</ArticleId><ArticleId IdType="pmc">PMC4981810</ArticleId><ArticleId IdType="pubmed">27459450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW, L&#xf6;we B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613-621. doi:10.1176/appi.psy.50.6.613</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.50.6.613</ArticleId><ArticleId IdType="pubmed">19996233</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284-1292. doi:10.1097/01.MLR.0000093487.78664.3C</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000093487.78664.3C</ArticleId><ArticleId IdType="pubmed">14583691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW, Monahan PO, L&#xf6;we B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317-325. doi:10.7326/0003-4819-146-5-200703060-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-146-5-200703060-00004</ArticleId><ArticleId IdType="pubmed">17339617</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;we B, Wahl I, Rose M, et al. . A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1-2):86-95. doi:10.1016/j.jad.2009.06.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2009.06.019</ArticleId><ArticleId IdType="pubmed">19616305</ArticleId></ArticleIdList></Reference><Reference><Citation>YouGov . Yahoo! News Coronavirus: April 8, 2020. Accessed November 22, 2021. https://docs.cdn.yougov.com/1ayt0i64g6/20200408_yahoo_coronavirus.pdf</Citation></Reference><Reference><Citation>Mitchell AM, Crane PA, Kim Y. Perceived stress in survivors of suicide: psychometric properties of the Perceived Stress Scale. Res Nurs Health. 2008;31(6):576-585. doi:10.1002/nur.20284</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nur.20284</ArticleId><ArticleId IdType="pubmed">18449942</ArticleId></ArticleIdList></Reference><Reference><Citation>Warttig SL, Forshaw MJ, South J, White AK. New, normative, English-sample data for the short form Perceived Stress Scale (PSS-4). J Health Psychol. 2013;18(12):1617-1628. doi:10.1177/1359105313508346</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105313508346</ArticleId><ArticleId IdType="pubmed">24155195</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes ME, Waite LJ, Hawkley LC, Cacioppo JT. A short scale for measuring loneliness in large surveys: results from two population-based studies. Res Aging. 2004;26(6):655-672. doi:10.1177/0164027504268574</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0164027504268574</ArticleId><ArticleId IdType="pmc">PMC2394670</ArticleId><ArticleId IdType="pubmed">18504506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Ding M, et al. . Depression, worry, and loneliness are associated with subsequent risk of hospitalization for COVID-19: a prospective study. Psychol Med. 2022;1-10. Published online 2022. doi:10.1017/S0033291722000691</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291722000691</ArticleId><ArticleId IdType="pmc">PMC9924056</ArticleId><ArticleId IdType="pubmed">35586906</ArticleId></ArticleIdList></Reference><Reference><Citation>van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16(3):219-242. doi:10.1177/0962280206074463</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280206074463</ArticleId><ArticleId IdType="pubmed">17621469</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S, Tyrrell DAJ, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. 1991;325(9):606-612. doi:10.1056/NEJM199108293250903</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199108293250903</ArticleId><ArticleId IdType="pubmed">1713648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassett AL, Radvanski DC, Buyske S, et al. . Role of psychiatric comorbidity in chronic Lyme disease. Arthritis Rheum. 2008;59(12):1742-1749. doi:10.1002/art.24314</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24314</ArticleId><ArticleId IdType="pubmed">19035409</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassett AL, Radvanski DC, Buyske S, Savage SV, Sigal LH. Psychiatric comorbidity and other psychological factors in patients with &#x201c;chronic Lyme disease&#x201d;. Am J Med. 2009;122(9):843-850. doi:10.1016/j.amjmed.2009.02.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2009.02.022</ArticleId><ArticleId IdType="pmc">PMC2751626</ArticleId><ArticleId IdType="pubmed">19699380</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon SP, Hilton E, Weinschel BS, Pollack S, Grolnick E. Psychological factors in the prediction of Lyme disease course. Arthritis Care Res. 1998;11(5):419-426. doi:10.1002/art.1790110514</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1790110514</ArticleId><ArticleId IdType="pubmed">9830887</ArticleId></ArticleIdList></Reference><Reference><Citation>Wormser GP, McKenna D, Shaffer KD, Silverman JH, Scavarda C, Visintainer P. Evaluation of selected variables to determine if any had predictive value for, or correlated with, residual symptoms at approximately 12 months after diagnosis and treatment of early Lyme disease. Diagn Microbiol Infect Dis. 2021;100(3):115348. doi:10.1016/j.diagmicrobio.2021.115348</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2021.115348</ArticleId><ArticleId IdType="pubmed">33774355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe M, Carson A. &#x201c;Unexplained&#x201d; somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift? Ann Intern Med. 2001;134(9 pt 2):926-930. doi:10.7326/0003-4819-134-9_Part_2-200105011-00018</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-134-9_Part_2-200105011-00018</ArticleId><ArticleId IdType="pubmed">11346330</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker J, Sharpe M, Wessely S. Commentary: symptoms not associated with disease: an unmet public health challenge. Int J Epidemiol. 2006;35(2):477-478. doi:10.1093/ije/dyl035</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyl035</ArticleId><ArticleId IdType="pubmed">16510535</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine J. The dubious origins of long Covid. Wall Street Journal. Published March 22, 2021. Accessed December 20, 2021. https://www.wsj.com/articles/the-dubious-origins-of-long-covid-11616452583</Citation></Reference><Reference><Citation>First MB. DSM-5 Handbook of Differential Diagnosis. American Psychiatric Association; 2013.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi:10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf S, Seiffer B, Zeibig JM, et al. . Is physical activity associated with less depression and anxiety during the COVID-19 pandemic? a rapid systematic review. Sports Med. 2021;51(8):1771-1783. doi:10.1007/s40279-021-01468-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-021-01468-z</ArticleId><ArticleId IdType="pmc">PMC8060908</ArticleId><ArticleId IdType="pubmed">33886101</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, et al. ; COVID-19 BioB Outpatient Clinic Study group . Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138-147. doi:10.1016/j.bbi.2021.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, et al. ; COVID-19 BioB Outpatient Clinic Study group . Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594-600. doi:10.1016/j.bbi.2020.07.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374(1648):n1648. doi:10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Costenaro P, Minotti C, Barbieri E, Giaquinto C, Don&#xe0; D. SARS-CoV-2 infection in people living with HIV: a systematic review. Rev Med Virol. 2021;31(1):1-12. doi:10.1002/rmv.2155</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2155</ArticleId><ArticleId IdType="pubmed">32875716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalska JD, Kase K, Vassilenko A, et al. . The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease: a report from Central and Eastern Europe. Int J Infect Dis. 2021;104:293-296. doi:10.1016/j.ijid.2020.12.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.12.026</ArticleId><ArticleId IdType="pmc">PMC7834141</ArticleId><ArticleId IdType="pubmed">33326871</ArticleId></ArticleIdList></Reference><Reference><Citation>Iseme RA, McEvoy M, Kelly B, Agnew L, Attia J, Walker FR. Autoantibodies and depression: evidence for a causal link? Neurosci Biobehav Rev. 2014;40:62-79. doi:10.1016/j.neubiorev.2014.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2014.01.008</ArticleId><ArticleId IdType="pubmed">24480318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondelli V, Pariante CM. What can neuroimmunology teach us about the symptoms of long-COVID? Oxf Open Immunol. 2021;2(1):iqab004. doi:10.1093/oxfimm/iqab004</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqab004</ArticleId><ArticleId IdType="pmc">PMC7928677</ArticleId><ArticleId IdType="pubmed">34192271</ArticleId></ArticleIdList></Reference><Reference><Citation>Su L, Cai Y, Xu Y, Dutt A, Shi S, Bramon E. Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies. BMC Psychiatry. 2014;14:321. doi:10.1186/s12888-014-0321-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-014-0321-9</ArticleId><ArticleId IdType="pmc">PMC4240898</ArticleId><ArticleId IdType="pubmed">25407081</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayberg HS, Lewis PJ, Regenold W, Wagner HN Jr. Paralimbic hypoperfusion in unipolar depression. J Nucl Med. 1994;35(6):929-934.</Citation><ArticleIdList><ArticleId IdType="pubmed">8195877</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Million M, Dudouet P, et al. . 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2021;48(2):592-595. doi:10.1007/s00259-020-04973-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04973-x</ArticleId><ArticleId IdType="pmc">PMC7391029</ArticleId><ArticleId IdType="pubmed">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Troy LM, Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Willett WC. The validity of recalled weight among younger women. Int J Obes Relat Metab Disord. 1995;19(8):570-572.</Citation><ArticleIdList><ArticleId IdType="pubmed">7489028</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008;52(5):828-832. doi:10.1161/HYPERTENSIONAHA.108.117630</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.108.117630</ArticleId><ArticleId IdType="pmc">PMC2747298</ArticleId><ArticleId IdType="pubmed">18838623</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Shilo S, Rossman H, et al. . Longitudinal symptom dynamics of COVID-19 infection. Nat Commun. 2020;11(1):6208. doi:10.1038/s41467-020-20053-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20053-y</ArticleId><ArticleId IdType="pmc">PMC7718370</ArticleId><ArticleId IdType="pubmed">33277494</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>